Respostas Clínicas Cochrane
As Respostas Clínicas Cochrane (RCCs) proporcionam um ponto de entrada amigável, digerível e clinicamente focado para as pesquisas rigorosas das revisões sistemáticas Cochrane. Elas são desenvolvidas para serem acionáveis e para respaldar a tomada de decisão no local de atendimento, e foram adicionadas a seções relevantes do texto principal do Best Practice.
- In preterm or low birth weight infants, do cyclo‐oxygenase inhibitors (COX‐I) help prevent morbidity and mortality?
- What are the effects of prostaglandin inhibitor drugs for the treatment of symptomatic patent ductus arteriosus (PDA)?
- How does ibuprofen compare with standard indomethacin therapy for preterm/low birth weight infants with patent ductus arteriosus (PDA)?
- In preterm infants with symptomatic patent ductus arteriosus, what are the benefits and harms of surgical compared with medical treatment with indomethacin?
- How does paracetamol (acetaminophen) compare with other interventions for treating preterm or low‐birthweight infants with patent ductus arteriosus (PDA)?
O uso deste conteúdo está sujeito ao nosso aviso legal